CL
CRDF icon

CSS LLC’s Cardiff Oncology CRDF Stock Holding History

CSS LLC’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,920
Closed -$55K – 981
2022
Q3 		$55K Buy
35,920
+3,926
+12% +$9.45K ﹤0.01% 876
2022
Q2 		$70K Hold
31,994
– – ﹤0.01% 920
2022
Q1 		$79K Buy
31,994
+15,800
+98% +$55.9K ﹤0.01% 962
2021
Q4 		$97K Hold
16,194
– – ﹤0.01% 1023
2021
Q3 		$108K Sell
16,194
-17,519
-52% -$110K ﹤0.01% 967
2021
Q2 		$224K Buy
+33,713
New +$286K 0.01% 826
2021
Q1 		– Sell
-8,955
Closed -$161K – 952
2020
Q4 		$161K Buy
+8,955
New +$157K 0.01% 660

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CSS LLC's CRDF Position: Q4 2022 in Review

CSS LLC sold out of Cardiff Oncology (CRDF) in Q4 2022, closing a stake of 35,920 shares — an estimated $55K sold.

CSS LLC first reported a position in CRDF in Q4 2020 and held it in 7 quarters. The position peaked at $224K in Q2 2021. 58 funds tracked by Wall St. Rank hold CRDF as of Q4 2022.

  • CSS LLC reported no remaining Cardiff Oncology position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 35,920 Cardiff Oncology shares in Q4 2022, an estimated $55K.
  • CSS LLC first reported a position in Cardiff Oncology in Q4 2020 and held it in 7 quarters.
  • CSS LLC's Cardiff Oncology position peaked at $224K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.